Definitive Healthcare DH
- Market cap
- $115.3M
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 0.5×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $232.7M
- −5% on a year ago
- Net margin
- −72.3%
- Free cash flow yield
- 24.8%
Definitive Healthcare trades at 0.5× sales. Its trailing earnings are negative, so it has no PE. Revenue was $232.7M over the last twelve months, down 5% on a year earlier with a −72% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $65.3M+14% | $65.9M+9% | $63.5M+7% | $63.7M+5% | $62.7M−4% | $62.3M−6% | $59.2M−7% | $60.8M−5% | $60M−4% | $61.5M−1% | $55.9M−6% | $55.2M−9% | |
| Cost of revenue | $11.9M+22% | $12.5M+28% | $13.1M+10% | $13.3M+19% | $13.7M+15% | $14.7M+17% | $15.4M+18% | $14.1M+6% | $14.1M+3% | $14.6M−0% | $14.3M−8% | $14.7M+4% |
| Gross profit | $53.4M+12% | $53.4M+5% | $50.4M+7% | $50.5M+1% | $49M−8% | $47.6M−11% | $43.8M−13% | $46.6M−8% | $46M−6% | $46.9M−2% | $41.6M−5% | $40.5M−13% |
| R&D | $10.8M+17% | $11.6M+14% | $10.1M+3% | $10.1M−1% | $7.3M−32% | $9M−22% | $9.3M−8% | $8M−21% | $7.6M+4% | $10M+11% | $6.5M−30% | $6.8M−15% |
| SG&A | $37.3M+5% | $40.2M+1% | $38.6M+3% | $34.1M−11% | $31.5M−16% | $28.9M−28% | $32.9M−15% | $33.1M−3% | $32.7M+4% | $34.5M+19% | $31.7M−4% | $30M−10% |
| −$295.4M+2836% | −$10.1M−4% | −$16.2M+32% | −$369.6M+2962% | −$225.4M−24% | −$99.6M+888% | −$184.8M+1037% | −$4.2M−99% | −$8.7M−96% | −$26.6M−73% | −$201.3M+9% | −$6.7M+62% | |
| Interest expense | $3.9M+27% | $3.9M+163% | $3.8M+6% | $3.8M−1% | $3.7M−4% | $3.5M−10% | $2.4M−36% | $3M−21% | $3M−20% | $2.9M−18% | $2.6M+8% | $2.6M−12% |
| Pre-tax income | −$266.2M+3758% | −$12.2M+9% | −$13.5M−19% | −$328.1M+2407% | −$201.5M−24% | −$90.6M+644% | −$166M+1130% | −$8.8M−97% | −$17.3M−91% | −$17.2M−81% | −$195.8M+18% | −$7.8M−12% |
| −$17.5M+116793% | $1.2M | −$780K+10% | −$21.9M+1376% | −$13.7M−22% | −$5.9M | −$10.9M+1296% | $456K | $524K | −$53K−99% | −$3.4M−68% | −$345K | |
| Net income | −$171.5M+5580% | −$10.2M | −$9.5M−21% | −$213.6M+2394% | −$130.9M−24% | −$59.1M+477% | −$107.2M+1027% | −$7.6M−97% | −$14.8M−89% | −$9.3M−84% | −$138.6M+29% | −$5.4M−28% |
| −$1.50+4900% | −$0.09 | −$0.08−27% | −$1.81+2163% | −$1.12−25% | −$0.51+467% | −$0.95+1088% | −$0.07−96% | −$0.14−88% | −$0.09−82% | −$1.32+39% | −$0.05−29% | |
| 114.5M+11% | 116.4M−24% | 117.4M+9% | 117.8M+5% | 116.4M+2% | 115M−1% | 112.8M−4% | 106.8M−9% | 103.8M−11% | 103.4M−10% | 104.7M−7% | 105.8M−1% |
EPS, diluted: 3 periods, Q4 FY23 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 3 periods, Q4 FY23 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Software - Infrastructure nearest Definitive Healthcare's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| DHDefinitive Healthcare | $115.3M | n/m | n/a | 0.5× | −5% | −72.3% | |
| NTWKNetsol Technologies | $93.9M | 31.4× | 22.2× | 1.3× | +13% | 4.0% | |
| EGANEGAIN | $148.7M | 17.8× | 51.1× | 1.6× | +3% | 9.7% | |
| FATNFatpipe | $75.3M | 13.7× | 17.2× | 3.7× | +23% | n/m | |
| CCLDCareCloud | $75.2M | 25.3× | 37.4× | 0.6× | +15% | 6.2% | |
| WFCFWhere Food Comes From | $74.6M | 53.5× | 42.3× | 3.0× | −2% | 5.8% | |
| MKLYMcKinley Acquisition | $250M | 30.2× | 35.0× | n/m | n/m | n/m | |
| RBBNRibbon Communications | $250.4M | 17.5× | 18.7× | 0.3× | −8% | 2.0% | |
| IDNIntellicheck | $49.5M | 16.3× | 39.8× | 2.1× | +17% | 13.0% | |
| MKTWMarketwise | $297M | 21.6× | 7.4× | 0.9× | −11% | 0.7% | |
| IIIVi3 Verticals | $457.2M | 54.3× | 200× | 2.1× | −0% | 3.9% | |
| Peer median | $121.3M | 23.5× | 36.2× | 1.6× | +3% | 4.9% |
More on Definitive Healthcare
Each number over time
- PE ratio
- Price to sales ratio
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #9of 345Technology stocks with the highest free cash flow yield
- #4of 121Infrastructure software stocks with the highest free cash flow yield
Its groups
About
- Industry
- Software - Infrastructure
- Sector
- Technology
Valuation data, not investment advice. Prices as of .